Development of the spectrophotometric method for quantitative determination of metronidazole in capsules
DOI:
https://doi.org/10.24959/nphj.15.2009Keywords:
metronidazole, capsules, spectroscopy, assayAbstract
Pathological conditions of the digestive system are quite common nowadays and rank first among other human diseases. Increasingly, both newly-diagnosed and recurrent cases of stomach ulcers, as well as duodenal ulcers are recorded. Among solid drug dosage forms capsules are considered to be the most rational since the drug substance exhibits a low degree of dispersion, which leads to better absorption, resists additional negative impact in the production process, as well as possesses a lower damaging action on the mucous membranes of the digestive tract, etc. Thereby capsules are more and more often recommended for use by preference. Therefore, developing a feasible method of quantitative determination of metronidazole in capsules – the method of spectrophotometry in the ultraviolet region of the spectrum has become particularly urgent since high performance liquid chromatography recommended by the BP and USP is not used widely in Ukraine. The object of research was metronidazole capsules. The research has found that the excipients have little effect on the absorption spectrum of metronidazole obtained by extraction with 0.1 M hydrochloric acid solution from the content of capsules. The test solution has been proven to be complied with the Beer-Lambert-Bouguer law within the concentration range of 0.5·10-3% – 3.0·10-3%. The certification of the method developed on the model mixtures and a production sample has confirmed its correctness. The average results uncertainty ε in the former case was 0.11%, whereas in the latter it constituted 0.70%.
References
Бевз Н.Ю., Грудько В.О., Георгіянц В.А. // Актуальні питання фармацевтичної і медичної науки та практики. – 2012. – №1. – С. 23-26.
Бобрицька Л.О., Назарова О.С. // Управління, економіка та забезпечення якості в фармації. – 2012. – №2. – С. 38-43.
Державна Фармакопея України / Державне підприємство «Науково-експертний фармакопейний центр». Доповнення 4. – 1-е вид. – Харків: РІРЕГ, 2011. – 538 с.
Євтіфєєва О.А., Проскуріна К.І., Хмельова М.О. // Вісник фармації. – 2013. – №2 . – С. 41-44.
Клінічна фармація (фармацевтична опіка): підруч. для студ. вищ. мед. (фармац.) навч. закл. / за ред. В.П. Черних, І.А. Зупанця. – Х.:НФаУ: Золоті сторінки, 2011. – 704 с.
Монайкіна Ю.В., Васюк С.О., Гладишев В.В.// Актуальні питання фармацевтичної і медичної науки та практики. – 2013. – №2. – С. 111-113.
Основи клінічної медицини: симптоми та синдроми в практичній фармації: навч. посіб. / за ред. В.П. Черних, І.А. Зупанця. – Х.: Золоті сторінки, 2010. – 92 с.
Технологія ліків промислового виробництва: підручн. в 2 ч. Ч.1. / під ред. В.І. Чуєшова. – Х.: Оригінал; Вид-во НФаУ, 2012. – 696 с.
Фармацевтичний аналіз: Навч. посіб. для студ. вищ. фармац. навч. закл. III-IV рівнів акредитації /за ред. проф. В.А. Георгіянц. – Х.: Вид-во НФаУ; Золоті сторінки, 2013. – 552 с.
Alahdab Y. O., Kalayci C. // World Journal of Gastroenterology. – 2014. - №20(18). – P. 5302-5307. [Електронний документ]. – Режим доступу: http://www.wjgnet.com/1007-9327/full/v20/i18/5302.htm.
British Pharmacopoeia. – London. The Stationary Office. – 2001. – Vol. 1-2. – 3199 p.
Chey W.D., Wong B.C. // Am J Gastroenterol. – 2007. - №102. – P.1808-1825. [Електронний документ]. – Режим доступу: http://www.nature.com/ajg/journal/v102/n8/full/ajg2007348a.
Clarke's Analysis of Drugs and Poisons [Electronic version] // London: Pharmaceutical Press. – 2005.
Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. // Gut. – 1997. – Vol. 41. – P. 8-13.
European Pharmacopoeia. Sixth edition. Volume 2.2. – Council of Europe: Strasbourg. – 2007. – P. 2414-2415.
Malfertheiner P., Bazzoli F., Delchier J.C., [at al.] // Lancet. - 2011. [Електронний документ]. – Режим доступу: http://www.thelancet.com /journals/lancet/article/PIIS0140-6736(11)60020-2/fulltext/
Malfertheiner P., Megraud F., O’Morain C., [at al.] // Gut. – 2012. – №61. – P. 646-664. [Електронний документ]. – Режим доступу: http://gut.bmj.com/content/61/5/646.long/
Malfertheiner P., Megraud F., O’Morain C., et al. // Gut. 2007. - №56. – P. 772-781. [Електронний документ]. Режим доступу: http://gut.bmj.com/content/56/6/772.long.
United States Pharmacopeia 26. – USP Convention Inc. – Rockville, 2007. [Electronic version].
Downloads
Published
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
